Global Nicotinamide Mononucleotide Supplement Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Nicotinamide Mononucleotide Supplement market size was valued at US$ 287 million in 2024 and is forecast to a readjusted size of USD 399 million by 2031 with a CAGR of 4.9% during review period.
NMN supplements may help improve insulin sensitivity and heart function and reduce tiredness with few side effects.
A dietary supplement is a manufactured product intended to supplement one's diet by taking a pill, capsule, tablet, powder, or liquid. A supplement can provide nutrients either extracted from food sources or that are synthetic in order to increase the quantity of their consumption. The class of nutrient compounds includes vitamins, minerals, fiber, fatty acids, and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols. Animals can also be a source of supplement ingredients, such as collagen from chickens or fish for example. These are also sold individually and in combination, and may be combined with nutrient ingredients. The European Commission has also established harmonized rules to help insure that food supplements are safe and appropriately labeled.
This report is a detailed and comprehensive analysis for global Nicotinamide Mononucleotide Supplement market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nicotinamide Mononucleotide Supplement market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Nicotinamide Mononucleotide Supplement market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Nicotinamide Mononucleotide Supplement market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Nicotinamide Mononucleotide Supplement market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nicotinamide Mononucleotide Supplement
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nicotinamide Mononucleotide Supplement market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Double Wood Supplements, Quicksilver Scientific, California Gold Nutrition, ProHealth Longevity, Renue by Science, Do Not Age, Nutriop, AFEGA Anti-Aging-Shop, Borealis, MAAC10 Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nicotinamide Mononucleotide Supplement market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Mononucleotide Supplement product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide Supplement, with price, sales quantity, revenue, and global market share of Nicotinamide Mononucleotide Supplement from 2020 to 2025.
Chapter 3, the Nicotinamide Mononucleotide Supplement competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Mononucleotide Supplement breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Nicotinamide Mononucleotide Supplement market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide Supplement.
Chapter 14 and 15, to describe Nicotinamide Mononucleotide Supplement sales channel, distributors, customers, research findings and conclusion.
NMN supplements may help improve insulin sensitivity and heart function and reduce tiredness with few side effects.
A dietary supplement is a manufactured product intended to supplement one's diet by taking a pill, capsule, tablet, powder, or liquid. A supplement can provide nutrients either extracted from food sources or that are synthetic in order to increase the quantity of their consumption. The class of nutrient compounds includes vitamins, minerals, fiber, fatty acids, and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols. Animals can also be a source of supplement ingredients, such as collagen from chickens or fish for example. These are also sold individually and in combination, and may be combined with nutrient ingredients. The European Commission has also established harmonized rules to help insure that food supplements are safe and appropriately labeled.
This report is a detailed and comprehensive analysis for global Nicotinamide Mononucleotide Supplement market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nicotinamide Mononucleotide Supplement market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Nicotinamide Mononucleotide Supplement market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Nicotinamide Mononucleotide Supplement market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Nicotinamide Mononucleotide Supplement market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nicotinamide Mononucleotide Supplement
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nicotinamide Mononucleotide Supplement market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Double Wood Supplements, Quicksilver Scientific, California Gold Nutrition, ProHealth Longevity, Renue by Science, Do Not Age, Nutriop, AFEGA Anti-Aging-Shop, Borealis, MAAC10 Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nicotinamide Mononucleotide Supplement market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Powder
- Tablets
- Solution
- Capsules
- Online Sales
- Pharmacy Sales
- Supermarket Sales
- Double Wood Supplements
- Quicksilver Scientific
- California Gold Nutrition
- ProHealth Longevity
- Renue by Science
- Do Not Age
- Nutriop
- AFEGA Anti-Aging-Shop
- Borealis
- MAAC10 Formulas
- Xi'an Angel Biotechnology Co., Ltd.
- Longevity Box
- Age Science
- Nutravita
- Hebei Paihang Import And Export Co., Ltd.
- Aeternum
- Toniiq
- ProNutrition
- Genex Formulas
- Physicians Longevity
- AlphaFit
- Mega NMN
- Lovita Foods
- Jarrow Formulas
- Body Union
- Peak Performance
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Mononucleotide Supplement product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide Supplement, with price, sales quantity, revenue, and global market share of Nicotinamide Mononucleotide Supplement from 2020 to 2025.
Chapter 3, the Nicotinamide Mononucleotide Supplement competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Mononucleotide Supplement breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Nicotinamide Mononucleotide Supplement market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide Supplement.
Chapter 14 and 15, to describe Nicotinamide Mononucleotide Supplement sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nicotinamide Mononucleotide Supplement Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Powder
1.3.3 Tablets
1.3.4 Solution
1.3.5 Capsules
1.4 Market Analysis by Application
1.4.1 Overview: Global Nicotinamide Mononucleotide Supplement Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Online Sales
1.4.3 Pharmacy Sales
1.4.4 Supermarket Sales
1.5 Global Nicotinamide Mononucleotide Supplement Market Size & Forecast
1.5.1 Global Nicotinamide Mononucleotide Supplement Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Nicotinamide Mononucleotide Supplement Sales Quantity (2020-2031)
1.5.3 Global Nicotinamide Mononucleotide Supplement Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Double Wood Supplements
2.1.1 Double Wood Supplements Details
2.1.2 Double Wood Supplements Major Business
2.1.3 Double Wood Supplements Nicotinamide Mononucleotide Supplement Product and Services
2.1.4 Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Double Wood Supplements Recent Developments/Updates
2.2 Quicksilver Scientific
2.2.1 Quicksilver Scientific Details
2.2.2 Quicksilver Scientific Major Business
2.2.3 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product and Services
2.2.4 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Quicksilver Scientific Recent Developments/Updates
2.3 California Gold Nutrition
2.3.1 California Gold Nutrition Details
2.3.2 California Gold Nutrition Major Business
2.3.3 California Gold Nutrition Nicotinamide Mononucleotide Supplement Product and Services
2.3.4 California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 California Gold Nutrition Recent Developments/Updates
2.4 ProHealth Longevity
2.4.1 ProHealth Longevity Details
2.4.2 ProHealth Longevity Major Business
2.4.3 ProHealth Longevity Nicotinamide Mononucleotide Supplement Product and Services
2.4.4 ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ProHealth Longevity Recent Developments/Updates
2.5 Renue by Science
2.5.1 Renue by Science Details
2.5.2 Renue by Science Major Business
2.5.3 Renue by Science Nicotinamide Mononucleotide Supplement Product and Services
2.5.4 Renue by Science Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Renue by Science Recent Developments/Updates
2.6 Do Not Age
2.6.1 Do Not Age Details
2.6.2 Do Not Age Major Business
2.6.3 Do Not Age Nicotinamide Mononucleotide Supplement Product and Services
2.6.4 Do Not Age Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Do Not Age Recent Developments/Updates
2.7 Nutriop
2.7.1 Nutriop Details
2.7.2 Nutriop Major Business
2.7.3 Nutriop Nicotinamide Mononucleotide Supplement Product and Services
2.7.4 Nutriop Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Nutriop Recent Developments/Updates
2.8 AFEGA Anti-Aging-Shop
2.8.1 AFEGA Anti-Aging-Shop Details
2.8.2 AFEGA Anti-Aging-Shop Major Business
2.8.3 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product and Services
2.8.4 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 AFEGA Anti-Aging-Shop Recent Developments/Updates
2.9 Borealis
2.9.1 Borealis Details
2.9.2 Borealis Major Business
2.9.3 Borealis Nicotinamide Mononucleotide Supplement Product and Services
2.9.4 Borealis Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Borealis Recent Developments/Updates
2.10 MAAC10 Formulas
2.10.1 MAAC10 Formulas Details
2.10.2 MAAC10 Formulas Major Business
2.10.3 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product and Services
2.10.4 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 MAAC10 Formulas Recent Developments/Updates
2.11 Xi'an Angel Biotechnology Co., Ltd.
2.11.1 Xi'an Angel Biotechnology Co., Ltd. Details
2.11.2 Xi'an Angel Biotechnology Co., Ltd. Major Business
2.11.3 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
2.11.4 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
2.12 Longevity Box
2.12.1 Longevity Box Details
2.12.2 Longevity Box Major Business
2.12.3 Longevity Box Nicotinamide Mononucleotide Supplement Product and Services
2.12.4 Longevity Box Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Longevity Box Recent Developments/Updates
2.13 Age Science
2.13.1 Age Science Details
2.13.2 Age Science Major Business
2.13.3 Age Science Nicotinamide Mononucleotide Supplement Product and Services
2.13.4 Age Science Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Age Science Recent Developments/Updates
2.14 Nutravita
2.14.1 Nutravita Details
2.14.2 Nutravita Major Business
2.14.3 Nutravita Nicotinamide Mononucleotide Supplement Product and Services
2.14.4 Nutravita Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Nutravita Recent Developments/Updates
2.15 Hebei Paihang Import And Export Co., Ltd.
2.15.1 Hebei Paihang Import And Export Co., Ltd. Details
2.15.2 Hebei Paihang Import And Export Co., Ltd. Major Business
2.15.3 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
2.15.4 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
2.16 Aeternum
2.16.1 Aeternum Details
2.16.2 Aeternum Major Business
2.16.3 Aeternum Nicotinamide Mononucleotide Supplement Product and Services
2.16.4 Aeternum Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Aeternum Recent Developments/Updates
2.17 Toniiq
2.17.1 Toniiq Details
2.17.2 Toniiq Major Business
2.17.3 Toniiq Nicotinamide Mononucleotide Supplement Product and Services
2.17.4 Toniiq Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Toniiq Recent Developments/Updates
2.18 ProNutrition
2.18.1 ProNutrition Details
2.18.2 ProNutrition Major Business
2.18.3 ProNutrition Nicotinamide Mononucleotide Supplement Product and Services
2.18.4 ProNutrition Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 ProNutrition Recent Developments/Updates
2.19 Genex Formulas
2.19.1 Genex Formulas Details
2.19.2 Genex Formulas Major Business
2.19.3 Genex Formulas Nicotinamide Mononucleotide Supplement Product and Services
2.19.4 Genex Formulas Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Genex Formulas Recent Developments/Updates
2.20 Physicians Longevity
2.20.1 Physicians Longevity Details
2.20.2 Physicians Longevity Major Business
2.20.3 Physicians Longevity Nicotinamide Mononucleotide Supplement Product and Services
2.20.4 Physicians Longevity Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Physicians Longevity Recent Developments/Updates
2.21 AlphaFit
2.21.1 AlphaFit Details
2.21.2 AlphaFit Major Business
2.21.3 AlphaFit Nicotinamide Mononucleotide Supplement Product and Services
2.21.4 AlphaFit Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 AlphaFit Recent Developments/Updates
2.22 Mega NMN
2.22.1 Mega NMN Details
2.22.2 Mega NMN Major Business
2.22.3 Mega NMN Nicotinamide Mononucleotide Supplement Product and Services
2.22.4 Mega NMN Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Mega NMN Recent Developments/Updates
2.23 Lovita Foods
2.23.1 Lovita Foods Details
2.23.2 Lovita Foods Major Business
2.23.3 Lovita Foods Nicotinamide Mononucleotide Supplement Product and Services
2.23.4 Lovita Foods Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Lovita Foods Recent Developments/Updates
2.24 Jarrow Formulas
2.24.1 Jarrow Formulas Details
2.24.2 Jarrow Formulas Major Business
2.24.3 Jarrow Formulas Nicotinamide Mononucleotide Supplement Product and Services
2.24.4 Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Jarrow Formulas Recent Developments/Updates
2.25 Body Union
2.25.1 Body Union Details
2.25.2 Body Union Major Business
2.25.3 Body Union Nicotinamide Mononucleotide Supplement Product and Services
2.25.4 Body Union Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Body Union Recent Developments/Updates
2.26 Peak Performance
2.26.1 Peak Performance Details
2.26.2 Peak Performance Major Business
2.26.3 Peak Performance Nicotinamide Mononucleotide Supplement Product and Services
2.26.4 Peak Performance Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Peak Performance Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NICOTINAMIDE MONONUCLEOTIDE SUPPLEMENT BY MANUFACTURER
3.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Manufacturer (2020-2025)
3.2 Global Nicotinamide Mononucleotide Supplement Revenue by Manufacturer (2020-2025)
3.3 Global Nicotinamide Mononucleotide Supplement Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Nicotinamide Mononucleotide Supplement by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Nicotinamide Mononucleotide Supplement Manufacturer Market Share in 2024
3.4.3 Top 6 Nicotinamide Mononucleotide Supplement Manufacturer Market Share in 2024
3.5 Nicotinamide Mononucleotide Supplement Market: Overall Company Footprint Analysis
3.5.1 Nicotinamide Mononucleotide Supplement Market: Region Footprint
3.5.2 Nicotinamide Mononucleotide Supplement Market: Company Product Type Footprint
3.5.3 Nicotinamide Mononucleotide Supplement Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Nicotinamide Mononucleotide Supplement Market Size by Region
4.1.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2031)
4.1.2 Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2031)
4.1.3 Global Nicotinamide Mononucleotide Supplement Average Price by Region (2020-2031)
4.2 North America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.3 Europe Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.4 Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.5 South America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.6 Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
5.2 Global Nicotinamide Mononucleotide Supplement Consumption Value by Type (2020-2031)
5.3 Global Nicotinamide Mononucleotide Supplement Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
6.2 Global Nicotinamide Mononucleotide Supplement Consumption Value by Application (2020-2031)
6.3 Global Nicotinamide Mononucleotide Supplement Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
7.2 North America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
7.3 North America Nicotinamide Mononucleotide Supplement Market Size by Country
7.3.1 North America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
7.3.2 North America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
8.2 Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
8.3 Europe Nicotinamide Mononucleotide Supplement Market Size by Country
8.3.1 Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
8.3.2 Europe Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Nicotinamide Mononucleotide Supplement Market Size by Region
9.3.1 Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
10.2 South America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
10.3 South America Nicotinamide Mononucleotide Supplement Market Size by Country
10.3.1 South America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
10.3.2 South America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Nicotinamide Mononucleotide Supplement Market Size by Country
11.3.1 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Nicotinamide Mononucleotide Supplement Market Drivers
12.2 Nicotinamide Mononucleotide Supplement Market Restraints
12.3 Nicotinamide Mononucleotide Supplement Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Nicotinamide Mononucleotide Supplement and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nicotinamide Mononucleotide Supplement
13.3 Nicotinamide Mononucleotide Supplement Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nicotinamide Mononucleotide Supplement Typical Distributors
14.3 Nicotinamide Mononucleotide Supplement Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nicotinamide Mononucleotide Supplement Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Powder
1.3.3 Tablets
1.3.4 Solution
1.3.5 Capsules
1.4 Market Analysis by Application
1.4.1 Overview: Global Nicotinamide Mononucleotide Supplement Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Online Sales
1.4.3 Pharmacy Sales
1.4.4 Supermarket Sales
1.5 Global Nicotinamide Mononucleotide Supplement Market Size & Forecast
1.5.1 Global Nicotinamide Mononucleotide Supplement Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Nicotinamide Mononucleotide Supplement Sales Quantity (2020-2031)
1.5.3 Global Nicotinamide Mononucleotide Supplement Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Double Wood Supplements
2.1.1 Double Wood Supplements Details
2.1.2 Double Wood Supplements Major Business
2.1.3 Double Wood Supplements Nicotinamide Mononucleotide Supplement Product and Services
2.1.4 Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Double Wood Supplements Recent Developments/Updates
2.2 Quicksilver Scientific
2.2.1 Quicksilver Scientific Details
2.2.2 Quicksilver Scientific Major Business
2.2.3 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product and Services
2.2.4 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Quicksilver Scientific Recent Developments/Updates
2.3 California Gold Nutrition
2.3.1 California Gold Nutrition Details
2.3.2 California Gold Nutrition Major Business
2.3.3 California Gold Nutrition Nicotinamide Mononucleotide Supplement Product and Services
2.3.4 California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 California Gold Nutrition Recent Developments/Updates
2.4 ProHealth Longevity
2.4.1 ProHealth Longevity Details
2.4.2 ProHealth Longevity Major Business
2.4.3 ProHealth Longevity Nicotinamide Mononucleotide Supplement Product and Services
2.4.4 ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ProHealth Longevity Recent Developments/Updates
2.5 Renue by Science
2.5.1 Renue by Science Details
2.5.2 Renue by Science Major Business
2.5.3 Renue by Science Nicotinamide Mononucleotide Supplement Product and Services
2.5.4 Renue by Science Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Renue by Science Recent Developments/Updates
2.6 Do Not Age
2.6.1 Do Not Age Details
2.6.2 Do Not Age Major Business
2.6.3 Do Not Age Nicotinamide Mononucleotide Supplement Product and Services
2.6.4 Do Not Age Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Do Not Age Recent Developments/Updates
2.7 Nutriop
2.7.1 Nutriop Details
2.7.2 Nutriop Major Business
2.7.3 Nutriop Nicotinamide Mononucleotide Supplement Product and Services
2.7.4 Nutriop Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Nutriop Recent Developments/Updates
2.8 AFEGA Anti-Aging-Shop
2.8.1 AFEGA Anti-Aging-Shop Details
2.8.2 AFEGA Anti-Aging-Shop Major Business
2.8.3 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product and Services
2.8.4 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 AFEGA Anti-Aging-Shop Recent Developments/Updates
2.9 Borealis
2.9.1 Borealis Details
2.9.2 Borealis Major Business
2.9.3 Borealis Nicotinamide Mononucleotide Supplement Product and Services
2.9.4 Borealis Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Borealis Recent Developments/Updates
2.10 MAAC10 Formulas
2.10.1 MAAC10 Formulas Details
2.10.2 MAAC10 Formulas Major Business
2.10.3 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product and Services
2.10.4 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 MAAC10 Formulas Recent Developments/Updates
2.11 Xi'an Angel Biotechnology Co., Ltd.
2.11.1 Xi'an Angel Biotechnology Co., Ltd. Details
2.11.2 Xi'an Angel Biotechnology Co., Ltd. Major Business
2.11.3 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
2.11.4 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
2.12 Longevity Box
2.12.1 Longevity Box Details
2.12.2 Longevity Box Major Business
2.12.3 Longevity Box Nicotinamide Mononucleotide Supplement Product and Services
2.12.4 Longevity Box Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Longevity Box Recent Developments/Updates
2.13 Age Science
2.13.1 Age Science Details
2.13.2 Age Science Major Business
2.13.3 Age Science Nicotinamide Mononucleotide Supplement Product and Services
2.13.4 Age Science Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Age Science Recent Developments/Updates
2.14 Nutravita
2.14.1 Nutravita Details
2.14.2 Nutravita Major Business
2.14.3 Nutravita Nicotinamide Mononucleotide Supplement Product and Services
2.14.4 Nutravita Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Nutravita Recent Developments/Updates
2.15 Hebei Paihang Import And Export Co., Ltd.
2.15.1 Hebei Paihang Import And Export Co., Ltd. Details
2.15.2 Hebei Paihang Import And Export Co., Ltd. Major Business
2.15.3 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
2.15.4 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
2.16 Aeternum
2.16.1 Aeternum Details
2.16.2 Aeternum Major Business
2.16.3 Aeternum Nicotinamide Mononucleotide Supplement Product and Services
2.16.4 Aeternum Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Aeternum Recent Developments/Updates
2.17 Toniiq
2.17.1 Toniiq Details
2.17.2 Toniiq Major Business
2.17.3 Toniiq Nicotinamide Mononucleotide Supplement Product and Services
2.17.4 Toniiq Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Toniiq Recent Developments/Updates
2.18 ProNutrition
2.18.1 ProNutrition Details
2.18.2 ProNutrition Major Business
2.18.3 ProNutrition Nicotinamide Mononucleotide Supplement Product and Services
2.18.4 ProNutrition Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 ProNutrition Recent Developments/Updates
2.19 Genex Formulas
2.19.1 Genex Formulas Details
2.19.2 Genex Formulas Major Business
2.19.3 Genex Formulas Nicotinamide Mononucleotide Supplement Product and Services
2.19.4 Genex Formulas Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Genex Formulas Recent Developments/Updates
2.20 Physicians Longevity
2.20.1 Physicians Longevity Details
2.20.2 Physicians Longevity Major Business
2.20.3 Physicians Longevity Nicotinamide Mononucleotide Supplement Product and Services
2.20.4 Physicians Longevity Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Physicians Longevity Recent Developments/Updates
2.21 AlphaFit
2.21.1 AlphaFit Details
2.21.2 AlphaFit Major Business
2.21.3 AlphaFit Nicotinamide Mononucleotide Supplement Product and Services
2.21.4 AlphaFit Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 AlphaFit Recent Developments/Updates
2.22 Mega NMN
2.22.1 Mega NMN Details
2.22.2 Mega NMN Major Business
2.22.3 Mega NMN Nicotinamide Mononucleotide Supplement Product and Services
2.22.4 Mega NMN Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Mega NMN Recent Developments/Updates
2.23 Lovita Foods
2.23.1 Lovita Foods Details
2.23.2 Lovita Foods Major Business
2.23.3 Lovita Foods Nicotinamide Mononucleotide Supplement Product and Services
2.23.4 Lovita Foods Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Lovita Foods Recent Developments/Updates
2.24 Jarrow Formulas
2.24.1 Jarrow Formulas Details
2.24.2 Jarrow Formulas Major Business
2.24.3 Jarrow Formulas Nicotinamide Mononucleotide Supplement Product and Services
2.24.4 Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Jarrow Formulas Recent Developments/Updates
2.25 Body Union
2.25.1 Body Union Details
2.25.2 Body Union Major Business
2.25.3 Body Union Nicotinamide Mononucleotide Supplement Product and Services
2.25.4 Body Union Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Body Union Recent Developments/Updates
2.26 Peak Performance
2.26.1 Peak Performance Details
2.26.2 Peak Performance Major Business
2.26.3 Peak Performance Nicotinamide Mononucleotide Supplement Product and Services
2.26.4 Peak Performance Nicotinamide Mononucleotide Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Peak Performance Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NICOTINAMIDE MONONUCLEOTIDE SUPPLEMENT BY MANUFACTURER
3.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Manufacturer (2020-2025)
3.2 Global Nicotinamide Mononucleotide Supplement Revenue by Manufacturer (2020-2025)
3.3 Global Nicotinamide Mononucleotide Supplement Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Nicotinamide Mononucleotide Supplement by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Nicotinamide Mononucleotide Supplement Manufacturer Market Share in 2024
3.4.3 Top 6 Nicotinamide Mononucleotide Supplement Manufacturer Market Share in 2024
3.5 Nicotinamide Mononucleotide Supplement Market: Overall Company Footprint Analysis
3.5.1 Nicotinamide Mononucleotide Supplement Market: Region Footprint
3.5.2 Nicotinamide Mononucleotide Supplement Market: Company Product Type Footprint
3.5.3 Nicotinamide Mononucleotide Supplement Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Nicotinamide Mononucleotide Supplement Market Size by Region
4.1.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2031)
4.1.2 Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2031)
4.1.3 Global Nicotinamide Mononucleotide Supplement Average Price by Region (2020-2031)
4.2 North America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.3 Europe Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.4 Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.5 South America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
4.6 Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
5.2 Global Nicotinamide Mononucleotide Supplement Consumption Value by Type (2020-2031)
5.3 Global Nicotinamide Mononucleotide Supplement Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
6.2 Global Nicotinamide Mononucleotide Supplement Consumption Value by Application (2020-2031)
6.3 Global Nicotinamide Mononucleotide Supplement Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
7.2 North America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
7.3 North America Nicotinamide Mononucleotide Supplement Market Size by Country
7.3.1 North America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
7.3.2 North America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
8.2 Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
8.3 Europe Nicotinamide Mononucleotide Supplement Market Size by Country
8.3.1 Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
8.3.2 Europe Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Nicotinamide Mononucleotide Supplement Market Size by Region
9.3.1 Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
10.2 South America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
10.3 South America Nicotinamide Mononucleotide Supplement Market Size by Country
10.3.1 South America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
10.3.2 South America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Nicotinamide Mononucleotide Supplement Market Size by Country
11.3.1 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Nicotinamide Mononucleotide Supplement Market Drivers
12.2 Nicotinamide Mononucleotide Supplement Market Restraints
12.3 Nicotinamide Mononucleotide Supplement Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Nicotinamide Mononucleotide Supplement and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nicotinamide Mononucleotide Supplement
13.3 Nicotinamide Mononucleotide Supplement Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nicotinamide Mononucleotide Supplement Typical Distributors
14.3 Nicotinamide Mononucleotide Supplement Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Nicotinamide Mononucleotide Supplement Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Double Wood Supplements Basic Information, Manufacturing Base and Competitors
Table 4. Double Wood Supplements Major Business
Table 5. Double Wood Supplements Nicotinamide Mononucleotide Supplement Product and Services
Table 6. Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Double Wood Supplements Recent Developments/Updates
Table 8. Quicksilver Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Quicksilver Scientific Major Business
Table 10. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product and Services
Table 11. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Quicksilver Scientific Recent Developments/Updates
Table 13. California Gold Nutrition Basic Information, Manufacturing Base and Competitors
Table 14. California Gold Nutrition Major Business
Table 15. California Gold Nutrition Nicotinamide Mononucleotide Supplement Product and Services
Table 16. California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. California Gold Nutrition Recent Developments/Updates
Table 18. ProHealth Longevity Basic Information, Manufacturing Base and Competitors
Table 19. ProHealth Longevity Major Business
Table 20. ProHealth Longevity Nicotinamide Mononucleotide Supplement Product and Services
Table 21. ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. ProHealth Longevity Recent Developments/Updates
Table 23. Renue by Science Basic Information, Manufacturing Base and Competitors
Table 24. Renue by Science Major Business
Table 25. Renue by Science Nicotinamide Mononucleotide Supplement Product and Services
Table 26. Renue by Science Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Renue by Science Recent Developments/Updates
Table 28. Do Not Age Basic Information, Manufacturing Base and Competitors
Table 29. Do Not Age Major Business
Table 30. Do Not Age Nicotinamide Mononucleotide Supplement Product and Services
Table 31. Do Not Age Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Do Not Age Recent Developments/Updates
Table 33. Nutriop Basic Information, Manufacturing Base and Competitors
Table 34. Nutriop Major Business
Table 35. Nutriop Nicotinamide Mononucleotide Supplement Product and Services
Table 36. Nutriop Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Nutriop Recent Developments/Updates
Table 38. AFEGA Anti-Aging-Shop Basic Information, Manufacturing Base and Competitors
Table 39. AFEGA Anti-Aging-Shop Major Business
Table 40. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product and Services
Table 41. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. AFEGA Anti-Aging-Shop Recent Developments/Updates
Table 43. Borealis Basic Information, Manufacturing Base and Competitors
Table 44. Borealis Major Business
Table 45. Borealis Nicotinamide Mononucleotide Supplement Product and Services
Table 46. Borealis Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Borealis Recent Developments/Updates
Table 48. MAAC10 Formulas Basic Information, Manufacturing Base and Competitors
Table 49. MAAC10 Formulas Major Business
Table 50. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product and Services
Table 51. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. MAAC10 Formulas Recent Developments/Updates
Table 53. Xi'an Angel Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Xi'an Angel Biotechnology Co., Ltd. Major Business
Table 55. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
Table 56. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
Table 58. Longevity Box Basic Information, Manufacturing Base and Competitors
Table 59. Longevity Box Major Business
Table 60. Longevity Box Nicotinamide Mononucleotide Supplement Product and Services
Table 61. Longevity Box Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Longevity Box Recent Developments/Updates
Table 63. Age Science Basic Information, Manufacturing Base and Competitors
Table 64. Age Science Major Business
Table 65. Age Science Nicotinamide Mononucleotide Supplement Product and Services
Table 66. Age Science Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Age Science Recent Developments/Updates
Table 68. Nutravita Basic Information, Manufacturing Base and Competitors
Table 69. Nutravita Major Business
Table 70. Nutravita Nicotinamide Mononucleotide Supplement Product and Services
Table 71. Nutravita Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Nutravita Recent Developments/Updates
Table 73. Hebei Paihang Import And Export Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Hebei Paihang Import And Export Co., Ltd. Major Business
Table 75. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
Table 76. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
Table 78. Aeternum Basic Information, Manufacturing Base and Competitors
Table 79. Aeternum Major Business
Table 80. Aeternum Nicotinamide Mononucleotide Supplement Product and Services
Table 81. Aeternum Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Aeternum Recent Developments/Updates
Table 83. Toniiq Basic Information, Manufacturing Base and Competitors
Table 84. Toniiq Major Business
Table 85. Toniiq Nicotinamide Mononucleotide Supplement Product and Services
Table 86. Toniiq Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Toniiq Recent Developments/Updates
Table 88. ProNutrition Basic Information, Manufacturing Base and Competitors
Table 89. ProNutrition Major Business
Table 90. ProNutrition Nicotinamide Mononucleotide Supplement Product and Services
Table 91. ProNutrition Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. ProNutrition Recent Developments/Updates
Table 93. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 94. Genex Formulas Major Business
Table 95. Genex Formulas Nicotinamide Mononucleotide Supplement Product and Services
Table 96. Genex Formulas Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Genex Formulas Recent Developments/Updates
Table 98. Physicians Longevity Basic Information, Manufacturing Base and Competitors
Table 99. Physicians Longevity Major Business
Table 100. Physicians Longevity Nicotinamide Mononucleotide Supplement Product and Services
Table 101. Physicians Longevity Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Physicians Longevity Recent Developments/Updates
Table 103. AlphaFit Basic Information, Manufacturing Base and Competitors
Table 104. AlphaFit Major Business
Table 105. AlphaFit Nicotinamide Mononucleotide Supplement Product and Services
Table 106. AlphaFit Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. AlphaFit Recent Developments/Updates
Table 108. Mega NMN Basic Information, Manufacturing Base and Competitors
Table 109. Mega NMN Major Business
Table 110. Mega NMN Nicotinamide Mononucleotide Supplement Product and Services
Table 111. Mega NMN Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Mega NMN Recent Developments/Updates
Table 113. Lovita Foods Basic Information, Manufacturing Base and Competitors
Table 114. Lovita Foods Major Business
Table 115. Lovita Foods Nicotinamide Mononucleotide Supplement Product and Services
Table 116. Lovita Foods Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 117. Lovita Foods Recent Developments/Updates
Table 118. Jarrow Formulas Basic Information, Manufacturing Base and Competitors
Table 119. Jarrow Formulas Major Business
Table 120. Jarrow Formulas Nicotinamide Mononucleotide Supplement Product and Services
Table 121. Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 122. Jarrow Formulas Recent Developments/Updates
Table 123. Body Union Basic Information, Manufacturing Base and Competitors
Table 124. Body Union Major Business
Table 125. Body Union Nicotinamide Mononucleotide Supplement Product and Services
Table 126. Body Union Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 127. Body Union Recent Developments/Updates
Table 128. Peak Performance Basic Information, Manufacturing Base and Competitors
Table 129. Peak Performance Major Business
Table 130. Peak Performance Nicotinamide Mononucleotide Supplement Product and Services
Table 131. Peak Performance Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 132. Peak Performance Recent Developments/Updates
Table 133. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 134. Global Nicotinamide Mononucleotide Supplement Revenue by Manufacturer (2020-2025) & (USD Million)
Table 135. Global Nicotinamide Mononucleotide Supplement Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 136. Market Position of Manufacturers in Nicotinamide Mononucleotide Supplement, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 137. Head Office and Nicotinamide Mononucleotide Supplement Production Site of Key Manufacturer
Table 138. Nicotinamide Mononucleotide Supplement Market: Company Product Type Footprint
Table 139. Nicotinamide Mononucleotide Supplement Market: Company Product Application Footprint
Table 140. Nicotinamide Mononucleotide Supplement New Market Entrants and Barriers to Market Entry
Table 141. Nicotinamide Mononucleotide Supplement Mergers, Acquisition, Agreements, and Collaborations
Table 142. Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 143. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2025) & (K Units)
Table 144. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2026-2031) & (K Units)
Table 145. Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2025) & (USD Million)
Table 146. Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2026-2031) & (USD Million)
Table 147. Global Nicotinamide Mononucleotide Supplement Average Price by Region (2020-2025) & (US$/Unit)
Table 148. Global Nicotinamide Mononucleotide Supplement Average Price by Region (2026-2031) & (US$/Unit)
Table 149. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Global Nicotinamide Mononucleotide Supplement Consumption Value by Type (2020-2025) & (USD Million)
Table 152. Global Nicotinamide Mononucleotide Supplement Consumption Value by Type (2026-2031) & (USD Million)
Table 153. Global Nicotinamide Mononucleotide Supplement Average Price by Type (2020-2025) & (US$/Unit)
Table 154. Global Nicotinamide Mononucleotide Supplement Average Price by Type (2026-2031) & (US$/Unit)
Table 155. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 156. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 157. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Global Nicotinamide Mononucleotide Supplement Average Price by Application (2020-2025) & (US$/Unit)
Table 160. Global Nicotinamide Mononucleotide Supplement Average Price by Application (2026-2031) & (US$/Unit)
Table 161. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 162. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 163. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 164. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 165. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 166. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 167. North America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 168. North America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 169. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 170. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 171. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 172. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 173. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 174. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 175. Europe Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 176. Europe Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 177. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 178. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 179. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 180. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 181. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2025) & (K Units)
Table 182. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2026-2031) & (K Units)
Table 183. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2025) & (USD Million)
Table 184. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value by Region (2026-2031) & (USD Million)
Table 185. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 186. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 187. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 188. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 189. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 190. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 191. South America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 192. South America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 193. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 194. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 195. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 196. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 197. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 198. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 199. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 200. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 201. Nicotinamide Mononucleotide Supplement Raw Material
Table 202. Key Manufacturers of Nicotinamide Mononucleotide Supplement Raw Materials
Table 203. Nicotinamide Mononucleotide Supplement Typical Distributors
Table 204. Nicotinamide Mononucleotide Supplement Typical Customers
Table 1. Global Nicotinamide Mononucleotide Supplement Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Double Wood Supplements Basic Information, Manufacturing Base and Competitors
Table 4. Double Wood Supplements Major Business
Table 5. Double Wood Supplements Nicotinamide Mononucleotide Supplement Product and Services
Table 6. Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Double Wood Supplements Recent Developments/Updates
Table 8. Quicksilver Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Quicksilver Scientific Major Business
Table 10. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product and Services
Table 11. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Quicksilver Scientific Recent Developments/Updates
Table 13. California Gold Nutrition Basic Information, Manufacturing Base and Competitors
Table 14. California Gold Nutrition Major Business
Table 15. California Gold Nutrition Nicotinamide Mononucleotide Supplement Product and Services
Table 16. California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. California Gold Nutrition Recent Developments/Updates
Table 18. ProHealth Longevity Basic Information, Manufacturing Base and Competitors
Table 19. ProHealth Longevity Major Business
Table 20. ProHealth Longevity Nicotinamide Mononucleotide Supplement Product and Services
Table 21. ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. ProHealth Longevity Recent Developments/Updates
Table 23. Renue by Science Basic Information, Manufacturing Base and Competitors
Table 24. Renue by Science Major Business
Table 25. Renue by Science Nicotinamide Mononucleotide Supplement Product and Services
Table 26. Renue by Science Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Renue by Science Recent Developments/Updates
Table 28. Do Not Age Basic Information, Manufacturing Base and Competitors
Table 29. Do Not Age Major Business
Table 30. Do Not Age Nicotinamide Mononucleotide Supplement Product and Services
Table 31. Do Not Age Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Do Not Age Recent Developments/Updates
Table 33. Nutriop Basic Information, Manufacturing Base and Competitors
Table 34. Nutriop Major Business
Table 35. Nutriop Nicotinamide Mononucleotide Supplement Product and Services
Table 36. Nutriop Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Nutriop Recent Developments/Updates
Table 38. AFEGA Anti-Aging-Shop Basic Information, Manufacturing Base and Competitors
Table 39. AFEGA Anti-Aging-Shop Major Business
Table 40. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product and Services
Table 41. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. AFEGA Anti-Aging-Shop Recent Developments/Updates
Table 43. Borealis Basic Information, Manufacturing Base and Competitors
Table 44. Borealis Major Business
Table 45. Borealis Nicotinamide Mononucleotide Supplement Product and Services
Table 46. Borealis Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Borealis Recent Developments/Updates
Table 48. MAAC10 Formulas Basic Information, Manufacturing Base and Competitors
Table 49. MAAC10 Formulas Major Business
Table 50. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product and Services
Table 51. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. MAAC10 Formulas Recent Developments/Updates
Table 53. Xi'an Angel Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Xi'an Angel Biotechnology Co., Ltd. Major Business
Table 55. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
Table 56. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
Table 58. Longevity Box Basic Information, Manufacturing Base and Competitors
Table 59. Longevity Box Major Business
Table 60. Longevity Box Nicotinamide Mononucleotide Supplement Product and Services
Table 61. Longevity Box Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Longevity Box Recent Developments/Updates
Table 63. Age Science Basic Information, Manufacturing Base and Competitors
Table 64. Age Science Major Business
Table 65. Age Science Nicotinamide Mononucleotide Supplement Product and Services
Table 66. Age Science Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Age Science Recent Developments/Updates
Table 68. Nutravita Basic Information, Manufacturing Base and Competitors
Table 69. Nutravita Major Business
Table 70. Nutravita Nicotinamide Mononucleotide Supplement Product and Services
Table 71. Nutravita Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Nutravita Recent Developments/Updates
Table 73. Hebei Paihang Import And Export Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Hebei Paihang Import And Export Co., Ltd. Major Business
Table 75. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product and Services
Table 76. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
Table 78. Aeternum Basic Information, Manufacturing Base and Competitors
Table 79. Aeternum Major Business
Table 80. Aeternum Nicotinamide Mononucleotide Supplement Product and Services
Table 81. Aeternum Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Aeternum Recent Developments/Updates
Table 83. Toniiq Basic Information, Manufacturing Base and Competitors
Table 84. Toniiq Major Business
Table 85. Toniiq Nicotinamide Mononucleotide Supplement Product and Services
Table 86. Toniiq Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Toniiq Recent Developments/Updates
Table 88. ProNutrition Basic Information, Manufacturing Base and Competitors
Table 89. ProNutrition Major Business
Table 90. ProNutrition Nicotinamide Mononucleotide Supplement Product and Services
Table 91. ProNutrition Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. ProNutrition Recent Developments/Updates
Table 93. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 94. Genex Formulas Major Business
Table 95. Genex Formulas Nicotinamide Mononucleotide Supplement Product and Services
Table 96. Genex Formulas Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Genex Formulas Recent Developments/Updates
Table 98. Physicians Longevity Basic Information, Manufacturing Base and Competitors
Table 99. Physicians Longevity Major Business
Table 100. Physicians Longevity Nicotinamide Mononucleotide Supplement Product and Services
Table 101. Physicians Longevity Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Physicians Longevity Recent Developments/Updates
Table 103. AlphaFit Basic Information, Manufacturing Base and Competitors
Table 104. AlphaFit Major Business
Table 105. AlphaFit Nicotinamide Mononucleotide Supplement Product and Services
Table 106. AlphaFit Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. AlphaFit Recent Developments/Updates
Table 108. Mega NMN Basic Information, Manufacturing Base and Competitors
Table 109. Mega NMN Major Business
Table 110. Mega NMN Nicotinamide Mononucleotide Supplement Product and Services
Table 111. Mega NMN Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Mega NMN Recent Developments/Updates
Table 113. Lovita Foods Basic Information, Manufacturing Base and Competitors
Table 114. Lovita Foods Major Business
Table 115. Lovita Foods Nicotinamide Mononucleotide Supplement Product and Services
Table 116. Lovita Foods Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 117. Lovita Foods Recent Developments/Updates
Table 118. Jarrow Formulas Basic Information, Manufacturing Base and Competitors
Table 119. Jarrow Formulas Major Business
Table 120. Jarrow Formulas Nicotinamide Mononucleotide Supplement Product and Services
Table 121. Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 122. Jarrow Formulas Recent Developments/Updates
Table 123. Body Union Basic Information, Manufacturing Base and Competitors
Table 124. Body Union Major Business
Table 125. Body Union Nicotinamide Mononucleotide Supplement Product and Services
Table 126. Body Union Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 127. Body Union Recent Developments/Updates
Table 128. Peak Performance Basic Information, Manufacturing Base and Competitors
Table 129. Peak Performance Major Business
Table 130. Peak Performance Nicotinamide Mononucleotide Supplement Product and Services
Table 131. Peak Performance Nicotinamide Mononucleotide Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 132. Peak Performance Recent Developments/Updates
Table 133. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 134. Global Nicotinamide Mononucleotide Supplement Revenue by Manufacturer (2020-2025) & (USD Million)
Table 135. Global Nicotinamide Mononucleotide Supplement Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 136. Market Position of Manufacturers in Nicotinamide Mononucleotide Supplement, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 137. Head Office and Nicotinamide Mononucleotide Supplement Production Site of Key Manufacturer
Table 138. Nicotinamide Mononucleotide Supplement Market: Company Product Type Footprint
Table 139. Nicotinamide Mononucleotide Supplement Market: Company Product Application Footprint
Table 140. Nicotinamide Mononucleotide Supplement New Market Entrants and Barriers to Market Entry
Table 141. Nicotinamide Mononucleotide Supplement Mergers, Acquisition, Agreements, and Collaborations
Table 142. Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 143. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2025) & (K Units)
Table 144. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2026-2031) & (K Units)
Table 145. Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2025) & (USD Million)
Table 146. Global Nicotinamide Mononucleotide Supplement Consumption Value by Region (2026-2031) & (USD Million)
Table 147. Global Nicotinamide Mononucleotide Supplement Average Price by Region (2020-2025) & (US$/Unit)
Table 148. Global Nicotinamide Mononucleotide Supplement Average Price by Region (2026-2031) & (US$/Unit)
Table 149. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Global Nicotinamide Mononucleotide Supplement Consumption Value by Type (2020-2025) & (USD Million)
Table 152. Global Nicotinamide Mononucleotide Supplement Consumption Value by Type (2026-2031) & (USD Million)
Table 153. Global Nicotinamide Mononucleotide Supplement Average Price by Type (2020-2025) & (US$/Unit)
Table 154. Global Nicotinamide Mononucleotide Supplement Average Price by Type (2026-2031) & (US$/Unit)
Table 155. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 156. Global Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 157. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Global Nicotinamide Mononucleotide Supplement Average Price by Application (2020-2025) & (US$/Unit)
Table 160. Global Nicotinamide Mononucleotide Supplement Average Price by Application (2026-2031) & (US$/Unit)
Table 161. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 162. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 163. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 164. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 165. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 166. North America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 167. North America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 168. North America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 169. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 170. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 171. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 172. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 173. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 174. Europe Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 175. Europe Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 176. Europe Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 177. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 178. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 179. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 180. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 181. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2020-2025) & (K Units)
Table 182. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity by Region (2026-2031) & (K Units)
Table 183. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value by Region (2020-2025) & (USD Million)
Table 184. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value by Region (2026-2031) & (USD Million)
Table 185. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 186. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 187. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 188. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 189. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 190. South America Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 191. South America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 192. South America Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 193. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2020-2025) & (K Units)
Table 194. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Type (2026-2031) & (K Units)
Table 195. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2020-2025) & (K Units)
Table 196. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Application (2026-2031) & (K Units)
Table 197. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2020-2025) & (K Units)
Table 198. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity by Country (2026-2031) & (K Units)
Table 199. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value by Country (2020-2025) & (USD Million)
Table 200. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value by Country (2026-2031) & (USD Million)
Table 201. Nicotinamide Mononucleotide Supplement Raw Material
Table 202. Key Manufacturers of Nicotinamide Mononucleotide Supplement Raw Materials
Table 203. Nicotinamide Mononucleotide Supplement Typical Distributors
Table 204. Nicotinamide Mononucleotide Supplement Typical Customers
LIST OF FIGURES
Figure 1. Nicotinamide Mononucleotide Supplement Picture
Figure 2. Global Nicotinamide Mononucleotide Supplement Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type in 2024
Figure 4. Powder Examples
Figure 5. Tablets Examples
Figure 6. Solution Examples
Figure 7. Capsules Examples
Figure 8. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application in 2024
Figure 10. Online Sales Examples
Figure 11. Pharmacy Sales Examples
Figure 12. Supermarket Sales Examples
Figure 13. Global Nicotinamide Mononucleotide Supplement Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Nicotinamide Mononucleotide Supplement Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Nicotinamide Mononucleotide Supplement Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Nicotinamide Mononucleotide Supplement Price (2020-2031) & (US$/Unit)
Figure 17. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Nicotinamide Mononucleotide Supplement by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Nicotinamide Mononucleotide Supplement Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Nicotinamide Mononucleotide Supplement Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Nicotinamide Mononucleotide Supplement Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2020-2031)
Figure 34. Global Nicotinamide Mononucleotide Supplement Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 47. France Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Region (2020-2031)
Figure 55. China Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 58. India Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 75. Nicotinamide Mononucleotide Supplement Market Drivers
Figure 76. Nicotinamide Mononucleotide Supplement Market Restraints
Figure 77. Nicotinamide Mononucleotide Supplement Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide Supplement in 2024
Figure 80. Manufacturing Process Analysis of Nicotinamide Mononucleotide Supplement
Figure 81. Nicotinamide Mononucleotide Supplement Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Nicotinamide Mononucleotide Supplement Picture
Figure 2. Global Nicotinamide Mononucleotide Supplement Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type in 2024
Figure 4. Powder Examples
Figure 5. Tablets Examples
Figure 6. Solution Examples
Figure 7. Capsules Examples
Figure 8. Global Nicotinamide Mononucleotide Supplement Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application in 2024
Figure 10. Online Sales Examples
Figure 11. Pharmacy Sales Examples
Figure 12. Supermarket Sales Examples
Figure 13. Global Nicotinamide Mononucleotide Supplement Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Nicotinamide Mononucleotide Supplement Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Nicotinamide Mononucleotide Supplement Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Nicotinamide Mononucleotide Supplement Price (2020-2031) & (US$/Unit)
Figure 17. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Nicotinamide Mononucleotide Supplement by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Nicotinamide Mononucleotide Supplement Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Nicotinamide Mononucleotide Supplement Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Nicotinamide Mononucleotide Supplement Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2020-2031)
Figure 34. Global Nicotinamide Mononucleotide Supplement Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 47. France Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Region (2020-2031)
Figure 55. China Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 58. India Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Nicotinamide Mononucleotide Supplement Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Nicotinamide Mononucleotide Supplement Consumption Value (2020-2031) & (USD Million)
Figure 75. Nicotinamide Mononucleotide Supplement Market Drivers
Figure 76. Nicotinamide Mononucleotide Supplement Market Restraints
Figure 77. Nicotinamide Mononucleotide Supplement Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide Supplement in 2024
Figure 80. Manufacturing Process Analysis of Nicotinamide Mononucleotide Supplement
Figure 81. Nicotinamide Mononucleotide Supplement Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
